Stevens-Johnson Syndrome (SJS): A Comprehensive Guide

Overview

Stevens-Johnson Syndrome (SJS) is a rare but serious disorder that affects the skin and mucous membranes. It's often a severe allergic reaction to medication or an infection, leading to painful blisters and peeling of the skin. SJS is considered a medical emergency that requires hospitalization.

Who It Affects

While SJS can occur at any age, it's most commonly seen in:

• Adults over 40 years old
• Children and young adults with certain infections
• People with weakened immune systems (e.g., HIV/AIDS patients)
• Individuals with a genetic predisposition (especially those of Southeast Asian or European descent)

Prevalence

SJS is extremely rare, with an estimated incidence of:

• 1 to 6 cases per million people annually in the general population
• Higher rates in certain populations with specific genetic markers (e.g., HLA-B*1502 in Southeast Asians)

According to the National Institutes of Health (NIH), SJS accounts for about 1-2% of all adverse drug reactions requiring hospitalization.

Symptoms

SJS typically begins with flu-like symptoms, followed by a painful rash that spreads and blisters. Symptoms may include:

Early Symptoms (Prodromal Phase)

• Fever (usually above 102°F/39°C)
• Sore throat and cough
• Fatigue and general discomfort
• Burning eyes or eye pain
• Joint pain

Skin and Mucous Membrane Symptoms

• Painful rash: Starts as red or purplish spots that spread and merge, often beginning on the face and trunk.
• Blisters: Large blisters form on the skin, which then peel off, leaving raw, painful areas.
• Skin detachment: The top layer of skin may detach in sheets, similar to a severe burn.
• Mouth and lip sores: Painful ulcers and blisters in the mouth, making eating and drinking difficult.
• Eye involvement: Redness, swelling, discharge, and severe pain. In severe cases, vision loss can occur.
• Genital lesions: Painful sores in the genital and anal areas.

Severe Symptoms

• Widespread skin loss (affecting more than 10% of the body surface)
• Difficulty swallowing or breathing
• Signs of infection (e.g., pus, increased pain, fever)
• Dehydration due to inability to eat or drink

Symptoms typically develop within 1-3 weeks after starting a new medication or following an infection. The severity can vary, but SJS is always considered a medical emergency.

Causes and Risk Factors

Common Causes

SJS is most often triggered by:

• Medications: The leading cause, accounting for 75-90% of cases. Common culprits include:
  • Antibiotics (e.g., sulfamethoxazole, penicillins, cephalosporins)
  • Anticonvulsants (e.g., carbamazepine, lamotrigine, phenytoin)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, naproxen)
  • Allopurinol (used for gout)
  • Nevirapine (used for HIV)
• Infections: Viral or bacterial infections can trigger SJS, including:
  • Herpes simplex virus (HSV)
  • Mycoplasma pneumoniae (a type of bacterial pneumonia)
  • HIV
  • Hepatitis
  • Cytomegalovirus (CMV)
• Vaccinations: Rarely, vaccines (e.g., influenza, pneumococcal) may trigger SJS.

Risk Factors

Factors that increase the risk of developing SJS include:

• Genetic predisposition (e.g., carrying the HLA-B*1502 gene, common in Southeast Asians)
• Weakened immune system (e.g., HIV/AIDS, autoimmune diseases)
• History of previous allergic reactions to medications
• Concurrent use of multiple high-risk medications
• Slow metabolism of certain drugs (e.g., slow acetylators)

Diagnosis

SJS is diagnosed based on clinical symptoms, medical history, and sometimes laboratory tests. Early diagnosis is critical for improving outcomes.

Diagnostic Process

1. Medical History: Your doctor will ask about recent medications, infections, and symptoms.
2. Physical Examination: A thorough exam of the skin, mouth, eyes, and genital areas to assess the extent of the rash and blistering.
3. Skin Biopsy: A small sample of skin may be taken and examined under a microscope to confirm the diagnosis and rule out other conditions (e.g., toxic epidermal necrolysis, erythema multiforme).
4. Laboratory Tests: Blood tests may be done to check for infections, assess organ function, and identify possible triggers.
5. Eye Examination: An ophthalmologist may evaluate eye involvement to prevent long-term damage.

Differential Diagnosis

SJS may be confused with other conditions, such as:

• Toxic Epidermal Necrolysis (TEN): A more severe form of SJS with greater skin detachment.
• Erythema Multiforme: A milder skin reaction often triggered by infections.
• Staphylococcal Scalded Skin Syndrome: A bacterial infection causing skin peeling, common in children.
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Another severe drug reaction with different symptoms.

Treatment Options

SJS requires immediate hospitalization, often in a burn unit or intensive care unit (ICU). Treatment focuses on stopping the progression of the disease, managing symptoms, and preventing complications.

Immediate Actions

• Discontinue the offending medication: If a drug is suspected, it should be stopped immediately.
• Hydration and nutrition: Intravenous (IV) fluids and nutrients may be necessary if eating is painful.
• Pain management: Strong pain relievers (e.g., morphine) may be needed due to severe skin pain.

Medications

• Corticosteroids: High-dose steroids (e.g., prednisone) may be used to reduce inflammation, though their use is controversial and depends on the stage of the disease.
• Immunoglobulins (IVIG): Intravenous immunoglobulin therapy may help block the immune response causing SJS.
• Antibiotics: Used if there are signs of infection (e.g., sepsis) but not routinely, as they can worsen SJS if they are the trigger.
• Antihistamines or topical anesthetics: For itching or mouth pain (e.g., diphenhydramine, lidocaine mouthwash).

Supportive Care

• Wound care: Skin is treated similarly to burn wounds, with dressings and topical treatments to promote healing.
• Eye care: Lubricating drops, antibiotics, or corticosteroids to prevent eye damage.
• Mouth care: Regular rinsing with saline or antiseptic solutions to prevent infections.
• Physical therapy: To maintain mobility and prevent joint stiffness during recovery.

Experimental Treatments

Emerging treatments being studied include:

• Cyclosporine (an immunosuppressant)
• Tumor necrosis factor (TNF) inhibitors
• Plasmapheresis (blood filtration to remove antibodies)

Living with Stevens-Johnson Syndrome

Recovery from SJS can take weeks to months, depending on the severity. Long-term management focuses on preventing recurrence and addressing complications.

Daily Management Tips

• Avoid triggers: Steer clear of medications or infections that caused SJS. Wear a medical alert bracelet listing your allergies.
• Skin care: Use gentle, fragrance-free moisturizers to keep skin hydrated. Avoid harsh soaps or hot water.
• Eye care: Use artificial tears to prevent dryness. See an ophthalmologist regularly if you had eye involvement.
• Oral hygiene: Use a soft toothbrush and avoid spicy or acidic foods if mouth sores persist.
• Sun protection: New skin may be sensitive to sunlight. Use sunscreen (SPF 30+) and wear protective clothing.
• Pain management: Over-the-counter pain relievers (e.g., acetaminophen) may help with residual pain. Avoid NSAIDs unless approved by your doctor.

Emotional Support

SJS can be traumatic. Consider:

• Joining support groups (e.g., SJS Foundation)
• Counseling or therapy to address anxiety or PTSD
• Connecting with others who have experienced SJS

Prevention

While not all cases of SJS can be prevented, you can reduce your risk by:

• Knowing your risks: If you have a genetic predisposition (e.g., HLA-B*1502), avoid high-risk medications like carbamazepine.
• Medication history: Inform all healthcare providers about past allergic reactions. Ask about alternatives if you’ve had SJS.
• Gradual introduction: If you must take a high-risk medication, your doctor may start with a low dose and monitor closely.
• Infection control: Manage chronic infections (e.g., HSV) with antiviral medications if prescribed.
• Genetic testing: If you’re of Southeast Asian descent, consider testing for HLA-B*1502 before taking carbamazepine or similar drugs.

Complications

SJS can lead to serious short-term and long-term complications, including:

Short-Term Complications

• Infections: Open wounds increase the risk of bacterial infections (e.g., sepsis, cellulitis).
• Dehydration and malnutrition: Due to difficulty eating or drinking.
• Electrolyte imbalances: From fluid loss and poor intake.
• Respiratory issues: If blisters affect the lungs or airway.

Long-Term Complications

• Skin scarring: Permanent scars or changes in skin pigmentation.
• Eye damage: Chronic dryness, corneal scarring, or vision loss (in up to 35% of cases).
• Oral complications: Difficulty eating, chronic dry mouth, or dental problems.
• Genital or urinary issues: Scarring can lead to pain, strictures, or sexual dysfunction.
• Emotional trauma: Anxiety, depression, or post-traumatic stress disorder (PTSD).
• Recurrence: SJS can recur, especially if the trigger (e.g., medication) is encountered again.

According to the Mayo Clinic, the mortality rate for SJS is about 5-10%, but this increases with the severity of skin detachment and age.

When to Seek Emergency Care

Additional Resources

For more information, visit:

• Mayo Clinic - Stevens-Johnson Syndrome
• National Institutes of Health (NIH)
• Centers for Disease Control and Prevention (CDC)
• SJS Foundation
• World Health Organization (WHO)